New guidelines take positive approach to switching cancer biologics and their biosimilars

New government-funded guidelines promote a more positive approach to initiating biosimilars and switching from biologic drugs to their biosimilar in hospital settings. The new 2021 guiding principles, shared by MOGA, have been released as part of the Department of Health’s ‘Value in Prescribing’ initiative to promote uptake of biosimilars, updating previous guidance released in 2016. ...

Already a member?

Login to keep reading.

© 2022 the limbic